Villinger GmbH was founded in 1979 and has been developing systems for different industrial applications, with a focus on Aviation and Automotive. The company has developed a special heating technology which enables electrical surface heating based on semi-conductive coatings. The coatings are IPR of Villinger and are produced in-house and may be tailored to each application’s needs. These coatings are not only used for various heating-, & de-icing purposes. The energy efficiency of the coatings is close to 100% at a very low added mass of only about 150g/m2 of heated area and the heatable coatings have a self-controlling effect.
Besides being used for a novel hyperthermia system for the treatment of cancer patients, this technology has set the foundation for several other innovative systems. The permanent manufacturing establishment in Mieders (AT) has numerous facilities for the development of heating systems and the production of prototypes. Villinger GmbH is ISO 9001:2015 certified.
Danube Private University GmbH
At the DPU three research centres are established: the centre for digital technologies (Head: Univ.-Prof. Dr. Constantin von See MaHM), the centre biosiences (Head: Prof. Dr. Peter Engel) and the centre for general sciences (Head: Prof. Dr. Kurt. W. Alt). At the moment medical research projects are conducted at a national and international level with more than 30 partners from industry and academia. In addition the new research area “neurodegenerative diseases” (Head: Prof. Dr. Ralf Braun) will participate within this project as well as the centre of oral and maxillofacial surgery (OMS) under the direction of Univ. Prof. Dr. Drithan Turhani who is an internationally renowned surgeon and researcher. To remain at the leading edge of materials related medical research the DPU has established a research coordination centre which is also responsible for the quality assurance of all activities at the university and which is lead by Prof. Dr. Christoph Kleber.
At the moment the DPU is conducting a project and a field study to clarify whether a loss of smell / taste can be directly connected to an Covid-19 infection. Partner DPU is specialized in maxillofacial surgery, biomedical mechatronics, and material sciences. Besides of these activities, DPU will act as a hub for
further networking activities with producers of devices. DPU will provide access to treatment chairs in real dental environments to test the newly developed clean air devices in practice and will conduct microbiological monitoring of the to be treated ambient atmospheres.
Istituto Neurologico Mediterraneo Neuromed
Istituto Neurologico Mediterraneo Neuromed, according to regional and national programming, carries out health care, biomedical, clinical and translational research in neuroscience, confirming itself as a center of national reference. Neuromed is a center of excellence in the field of diagnosis and treatment of neurological, neurosurgical and oncological diseases as well as of chronic diseases and rare degenerativeCentral and Peripheral Nervous System disorders. The Institute is accredited with the National and Regional Health Service, for both activities of outpatient and hospitalization, with 41 clinical specialties.
It is recognized by the Italian Ministry of Health as Scientific Institute for Hospitalization, Treatment and Research (the Italian acronym is IRCCS). Research is carried out at the Research centre, and is essentially used to update knowledge and offer patients advanced care. Neuromed uses the translational method, a continuous information exchange between the laboratory and the clinical activity, which enables an excellent and timely assistance. Thanks to the intensive research carried out in the laboratories of the Research Centre, Neuromed can significantly contribute to the advancement in a number of research field including neurosciences, cardiovascular and genetic diseases, molecular medicine and stem cells, rare disease of the nervous system and sense organs as well as advanced therapies epilepsy. In addition, the collaborations with scientific networks and joint research projects have provided the Institute with an international prestige. The Research is one of the fundamental elements of the Neuromed Institute which makes use of modern laboratories and technologies, as well as the collaboration of several research organizations and researchers from around the world. The research activity is developed within the Departments, structured on several operating units:
Molecular, Pathology, Neuropharmacology, Neurogenetics, Neuropathology, Cellular and Molecular Neurobiology, Experimental Epilepsy, Movement disorders Neurobiology, Angio-Cardio-Neurology, Hypertension
Epilepsy, Alzheimer's disease, Cephaleas, Hypertension, Parkinson's Disease, Multiple Sclerosis, Neurogenetics, Vascular surgery, Stroke Unit
Molecular Pathology Department:
Neuropharmacology Unit, Neurogenetics Unit, Molecular Pathology Unit, Neuropathology Unit, Cell And Molecular Neurobiology Unit, Experimental Epilepsy Unit, Movement Disorders, Neurobiology Unit, Genomics And Epigenomics Unit
Neuro-Cardiovascular Disease Department:
Neuro and Cardiovascular Research, Hypertension Physiopathology Unit, Vascular Accidents, Physiopathology Unit
Neurology Department Neurology Unit, Neuropathophysiology Unit
Department of Epidemiology and Prevention:
Unit of Molecular and Nutritional Epidemiology
Diagnostic Imaging Department:
blood pressure transducers for remote evaluation in animal models of cardiovascular disease for the study of pathophysiological mechanisms underlying cardiovascular diseases and associated vascular, cardio and brain
Established in 2016, MDM projects began its activity as a boutique company for management and leading projects in the field of implementation on medical industry. Today, the Company coordinates activity in a wide variety of fields providing complementary professional services for customers of the medical and civil sector, in Israel and abroad: engineering documentation, technical inscription, maintenance, professional experiment consultation, implementation development and instruction, regulation and more.
Headquarters are in Israel, the main operation and organization are executed in Israel, R&D design is done in Israel and Belarus. Regulation and QA functions are executed in Israel, manufacturing lines are in China and Israel.
IonOXess GmbH is an Austrian SME and has been in operation since 2012 and is specialized on laboratory development, research, and accredited testing. IonOXess provides research and technological development to realize essential innovations for the next generation of green technologies and novel approaches for different industries including Industrial Engineering and Renewable Energy. IonOXess covers the entire spectrum from taking up emerging technologies, first proof of concept, via applied research to transferring these emerging technologies into specific applications, and up to demonstrators and prototyping. IonOXess enables innovation through its scientific-technological expertise, market experience and close customer relationships.
Lukas Bucher is an Austrian SME for research of directives and standards. With his years of experience, he is able to translate the regulatory information into practical use.
The company's focus is on procedures for CE conformity (risk assessments, research, calculations of the probability of failure of control technology equipment), explosion protection (infrastructure and machines), control technology and automation. He was working at a renowned medical technology company over several years. In August 2017 he has officially started working as a self-employed. His projects included for example conformity assessments according to machinery directive for machines of Rheinmetall AG (Nitrochemie) in Aschau am Inn, Germany for different machines for producing explosive materials. Various tasks like risk assessment, electrical planning, choosing of equipment, calculation of electrical circuits, interactions with notified bodies and drawing of hydraulic plans were necessary for more than 10 machines. An ongoing project is the supervision of the entire location (approximately 350 employees) with regard to explosion protection and machinery safety at Aenova-Group in Gronau an der Leine, Germany. Beside risk assessment, creation of explosion protection documents, calculations of safe circuits and explosion protection parameters of processes he does some electrical planning and document assessment (work instructions, safety instructions).
IonOxess/WaterPlus GmbH are also customers of him. They need a risk assessment of 3 air-cleaning machines inclusive constructive and document-technical consulting, conformity assessment procedure, determination of the circumstances – information gathering, standards research, creating of operating instructions and support for EMC-measurement. At the university of Innsbruck (Leopold-Franzens-Universität), he created box-system explosion protection documents and documents for the whole chemical logistics (20 rooms) and other parts of the campus. He also did lectures for department heads in relation to explosion protection. For the technical university of Vienna (TU Wien) he did some training for the modular concept for explosion protection. At the company Alcon/Ciba Vision (Novartis-Group) in Großwallstadt he created 2 risk assessments according to machinery directive and conformity-triggering
standard such as special regulations in Germany “Betriebssicherheitsverordnung”, “Gefahrstoffverordnung” and “TA Luft” for a regenerative post-combustion system for solvent exhaust air.
The company has also carried out a large number of equivalent projects with regard to CE conformity. Examples of this include lighting systems, a rapid oven, a game computer for children, ultrasonic welding presses and a few more.
Medical University of Innsbruck
Medical University of Innsbruck is a young research centre with a long tradition. The Jesuits established a grammar school in Innsbruck as early as 1562. These were the foundations of the University that was inaugurated by Emperor Leopold I on 15 October 1669 (thus the name ‘Leopold-Franzens University’). The Medical University of Innsbruck was one of the first four faculties (Philosophy 1669, Faculty of Law 1670, Faculty of Theology 1670 and Faculty of Medicine 1674) of the University of Innsbruck. It has been an important flagship for the university throughout its 340-year history.
Within the framework of the University Act of 2002, the medical faculty was separated from the Leopold-Franzens University, and in 2004 the Medical University of Innsbruck was established as a university in its own right. Today, the Med-Uni has some 3,000 students and 2,000 employees. It is the most important medical research and training facility in western Austria and the home university of many Tyroleans, South Tyroleans and students from the Province of Vorarlberg.
The Institute of Virology strives to contribute to a better prevention and therapy of virus infections in man. With this endeavor the section focuses on two areas: Research on antiviral therapy and viral vaccines as well as on clinical virology including virological/serological diagnostics.
Focuses on antiviral therapy and viral vaccines research
- Development of anti-cancer (oncolytic) viruses
- Development of immunologically optimed antibodies as therapy against cancer and infection
- Innovative vaccines against AIDS and cancer
Focuses on clinical virology
- Epidemiology of Human Papilloma Viruses (HPV) in Austria
- Herpes Viruses infections of the central nervous system
- New viruses / pathogens targeting the respiratory tract
- Development of viral resistance against anti-viral drugs